Skip to content
Open access

Associating a Polygenic Risk Score for Multiple Sclerosis with Brain MRI Metrics and Cognitive Performance in Healthy UK Biobank Participants.

2026 · Magnetic Resonance in Medical Sciences · Vol 25 4 · 0 citations
Medicine

TL;DR

In neurologically healthy individuals, a higher genetic burden for MS was associated with slower information processing speed in the highest-risk subgroup and with altered WM microstructure in the splenium of the corpus callosum.

Abstract

Purpose

Multiple sclerosis (MS) is a demyelinating disease of the central nervous system influenced by both genetic and environmental factors. Although a polygenic risk score for MS (MS-PRS) is associated with disease susceptibility, its relationship with white matter (WM) microstructure and cognition in neurologically healthy individuals remains unclear. This study investigated associations of MS-PRS with diffusion MRI metrics and cognitive function in healthy individuals.

Methods

This cross-sectional study included 35952 neurologically healthy UK Biobank participants with available MS-PRS, diffusion MRI, and cognitive data. Associations between MS-PRS and 11 cognitive measures were tested using generalized linear models adjusted for age, age squared, sex, genetic principal components, body mass index, and intracranial volume, with false discovery rate (FDR) correction. Participants were then stratified by MS-PRS quartiles. For cognitive measures showing significant associations in the highest MS-PRS group, follow-up analyses evaluated associations between MS-PRS and diffusion MRI metrics in WM regions previously associated with reaction time (RT). Mediation analysis was then performed.

Results

In the full sample, MS-PRS was not significantly associated with any cognitive measure after multiple-comparison correction. In the highest MS-PRS group, the higher MS-PRS was significantly associated with longer RT (β = 0.048, FDR-corrected P = 0.047). In the highest MS-PRS group, the higher MS-PRS was associated with higher mean diffusivity (MD) in the splenium of the corpus callosum (CC) (β = 0.021, FDR-corrected P = 0.024). MD in the splenium of the CC showed a small partial mediation effect on the association between MS-PRS and RT in the highest MS-PRS group (mediation effect 3.0%).

Conclusion

In neurologically healthy individuals, a higher genetic burden for MS was associated with slower information processing speed in the highest-risk subgroup and with altered WM microstructure in the splenium of the CC. These findings suggest that subtle WM differences may partly underlie the association between MS genetic susceptibility and cognitive performance.

Read PDF

Similar papers

Open access Aug 2026

Brain network biomarkers for diagnosis and clinical stratification in multiple sclerosis: a longitudinal study integrating individualised structural covariance MRI with high-density EEG

The iSCN approach identified reliable patterns of topological and connectivity impairment across MS and its clinical stratifications, providing insight into MS neuropathology and guiding future diagnostic and therapeutic biomarker development.

Rui Gao, Xuegang Song, Hanyue Zheng et al. · 0 citations
Open access Sep 2026

Pathway-specific polygenic risk scores reveal underlying mechanisms of cerebral small vessel disease

A validated WMH global-PRS is generated showing robust association with cSVD clinical complications and introduce a multi-cohort WMH ps-PRS framework that reveals candidate biological pathways with candidate biological associations across the lifespan and clinical outcomes.

T. D'Aoust, A. Tsuchida, C. Dufouil et al. · 0 citations
Open access Oct 2026

Potential association between dementia polygenic risk scores and subjective cognitive burden in a post-COVID cohort: a hypothesis-generating study

Coronavirus disease 2019 (COVID-19) may be associated with persistent subjective cognitive complaints, including difficulties with attention, memory, and executive function, in some individuals with post-acute sequelae of SARS-CoV-2 infection (PASC, “long COVID”). Inter-individual variability raises the possibility...

Aleemah Nasif, Punya Sunil, Ranajit Das · 0 citations
Open access Sep 2026

Cross-sectional relationships between memory scores and neurodegeneration biomarkers in patients with suspected cognitive impairment.

INTRODUCTION We aimed to examine whether additional metrics derived from the CERAD Word List Memory Test (WLMT) such as acquisition patterns, error frequencies, and consolidation efficiency, are associated with cerebrospinal fluid (CSF) biomarkers of amyloid and tau pathology, as well as magnetic resonance imaging (MRI...

Lynn Sahhar, Milena Albrecht, Jennifer Pahl et al. · 0 citations
Open access Aug 2026

A multiancestry polygenic risk score for Alzheimer’s disease is associated with cognitive decline and neuropathological hallmarks in diverse populations

An APOE-independent polygenic risk score for Alzheimer’s disease derived from multiancestry GWAS summary statistics shows consistent associations with cognitive, imaging, biomarker and neuropathological features in diverse populations.

N. Kurniansyah, S. Tasaki, H. Rehman et al. · 0 citations
Open access Sep 2026

T1 mapping in Alzheimer’s disease: a quantitative MRI study with amyloid-PET correlation

Quantitative T1 mapping (qT1) is a magnetic resonance imaging (MRI) biomarker of brain microstructural changes; however, its application in Alzheimer disease (AD) remains limited. We compared cortico-limbic qT1 values between patients with AD and healthy controls (HCs) and examined their relationship with amyloid burde...

L. Gualco, N. Montobbio, M. Losa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.